With the analysis among 3,069 patents, we discovered top 250 key players by total patent application. Janssen Pharmaceutica NV, Grünenthal GmbH, Purdue Pharma LP are dominant in this area. They take 16.94% of the total patent filing.
Antwerpen, Belgium
Patent: 218
Nordrhein-Westfalen, Germany
Patent: 165
Connecticut, United States
Patent: 137
Indiana, United States
Patent: 128
Connecticut, United States
Patent: 114
Connecticut, United States
Patent: 102
Theravance Biopharma R&D IP LLC
California, United States
Patent: 99
Pennsylvania, United States
Patent: 97
Luxembourg, Luxembourg
Patent: 87
Pennsylvania, United States
Patent: 78
With the analysis among 36 patents, we discovered top 9 start-ups by total patent application. BlackThorn Therapeutics, Inc., Epiodyne, Inc., AYUMI Pharmaceutical Corp. are active in this area.
BlackThorn Therapeutics, Inc.
California, United States
Patent: 14
California, United States
Patent: 8
AYUMI Pharmaceutical Corp.
California, United States
Patent: 3
Enalare Therapeutics, Inc.
Texas, United States
Patent: 1
Nalpropion Pharmaceuticals, Inc.
California, United States
Patent: 1
New York, United States
Patent: 1
With the analysis among related 587 patents applied in the last 5 years. We discover 136 most active companies in this area. The fast-growing Intra-Cellular Therapies, Inc., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Trevena, Inc. take 16.70% of patent filing during this period.
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 37
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 31
Pennsylvania, United States
Patent: 30
Connecticut, United States
Patent: 27
Esteve Pharmaceuticals S.A.
The Scripps Research Institute
California, United States
Patent: 21
BlackThorn Therapeutics, Inc.
California, United States
Patent: 14
Nirsum Laboratories, Inc.
Ontario, Canada
Patent: 12
With the analysis among related 587 patents in last 5 years, we discover 76 new entrants. BlackThorn Therapeutics, Inc., Nirsum Laboratories, Inc., Canopy Growth Corp. are the most active new entrants in this area.
BlackThorn Therapeutics, Inc.
California, United States
Patent: 14
Nirsum Laboratories, Inc.
Ontario, Canada
Patent: 12
Sichuan Haisco Pharmaceutical Co., Ltd.
Sichuan Sheng, China
Patent: 11
Humanwell Pharmaceutical US, Inc.
Missouri, United States
Patent: 8
California, United States
Patent: 8
Connecticut, United States
Patent: 8
Kentucky, United States
Patent: 7
With the analysis among 700 patents, we discovered top 72 universities and scientific research institutions by total patent application. University of Minnesota, The Scripps Research Institute, Albert Einstein College of Medicine, Inc. are dominant in this area. They take 20.00% of the total patent filing.
Minnesota, United States
Patent: 54
The Scripps Research Institute
California, United States
Patent: 39
Albert Einstein College of Medicine, Inc.
New York, United States
Patent: 38
The University of Chicago
Illinois, United States
Patent: 26
Rensselaer Polytechnic Institute
New York, United States
Patent: 23
University of Kansas Medical Center
Missouri, United States
Patent: 17
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 16
Virginia Commonwealth University
Virginia, United States
Patent: 16
The Curators of the University of Missouri
Missouri, United States
Patent: 16
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 13